Challenges and strategies for ocular posterior diseases therapy via non-invasive advanced drug delivery

被引:22
|
作者
Qi, Qi [1 ]
Wei, Yidan [1 ]
Zhang, Xin [1 ]
Guan, Jian [1 ]
Mao, Shirui [1 ]
机构
[1] Shenyang Pharmaceut Univ, Sch Pharm, 103 Wenhua Rd, Shenyang 110016, Peoples R China
关键词
Ocular posterior segment; Non-invasive; Topical drug delivery; Nanocarriers; NANOSTRUCTURED LIPID CARRIERS; RETINAL-PIGMENT EPITHELIUM; CONTACT-LENSES; TRIAMCINOLONE ACETONIDE; PHYSIOLOGICAL BARRIERS; POLYMERIC MICELLES; TEAR FILM; NANOPARTICLES; EYE; SEGMENT;
D O I
10.1016/j.jconrel.2023.07.055
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Posterior segment diseases, such as age-related macular degeneration (AMD) and diabetic retinopathy (DR) are vital factor that seriously threatens human vision health and quality of life, the treatment of which poses a great challenge to ophthalmologists and ophthalmic scientists. In particular, ocular posterior drug delivery in a noninvasive manner is highly desired but still faces many difficulties such as rapid drug clearance, limited permeability and low drug accumulation at the target site. At present, many novel non-invasive topical ocular drug delivery systems are under development aiming to improve drug delivery efficiency and biocompatibility for better therapy of posterior segment oculopathy. The purpose of this review is to present the challenges in the noninvasive treatment of posterior segment diseases, and to propose strategies to tackle these bottlenecks. First of all, barriers to ocular administration were introduced based on ocular physiological structure and behavior, including analysis and discussion on the influence of ocular structures on noninvasive posterior segment delivery. Thereafter, various routes of posterior drug delivery, both invasive and noninvasive, were illustrated, along with the respective anatomical obstacles that need to be overcome. The widespread and risky application of invasive drug delivery, and the need to develop non-invasive local drug delivery with alternative to injectable therapy were described. Absorption routes through topical administration and strategies to enhance ocular posterior drug delivery were then discussed. As a follow-up, an up-to-date research advances in non-invasive delivery systems for the therapy of ocular fundus lesions were presented, including different nanocarriers, contact lenses, and several other carriers. In conclusion, it seems feasible and promising to treat posterior oculopathy via non-invasive local preparations or in combination with appropriate devices.
引用
收藏
页码:191 / 211
页数:21
相关论文
共 50 条
  • [1] Iontophoresis: A non-invasive ocular drug delivery
    Eljarrat-Binstock, E
    Domb, AJ
    JOURNAL OF CONTROLLED RELEASE, 2006, 110 (03) : 479 - 489
  • [2] Innovative Strategies for Drug Delivery to the Ocular Posterior Segment
    Gabai, Andrea
    Zeppieri, Marco
    Finocchio, Lucia
    Salati, Carlo
    PHARMACEUTICS, 2023, 15 (07)
  • [3] Polymeric Micelles in Ocular Drug Delivery: Rationale, Strategies and Challenges
    Pepic, I.
    Lovric, J.
    Filipovic-Grcic, J.
    CHEMICAL AND BIOCHEMICAL ENGINEERING QUARTERLY, 2012, 26 (04) : 365 - 377
  • [4] Design of the ocular coil, a new device for non-invasive drug delivery
    Bertens, Christian J. F.
    Martino, Chiara
    van Osch, Marty C.
    Lataster, Arno
    Dias, Aylvin J. A. A.
    van den Biggelaar, Frank J. H. M.
    Tuinier, Remco
    Nuijts, Rudy M. M. A.
    Gijs, Marlies
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2020, 150 : 120 - 130
  • [5] Innovative Nanotechnology in Drug Delivery Systems for Advanced Treatment of Posterior Segment Ocular Diseases
    Wu, Yue
    Li, Xin
    Fu, Xueyu
    Huang, Xiaomin
    Zhang, Shenrong
    Zhao, Nan
    Ma, Xiaowei
    Saiding, Qimanguli
    Yang, Mei
    Tao, Wei
    Zhou, Xingtao
    Huang, Jinhai
    ADVANCED SCIENCE, 2024, 11 (32)
  • [6] Non-Invasive Iontophoretic Delivery of Cytochrome c to the Posterior Segment and Determination of Its Ocular Biodistribution
    Iglesias, Laura Gisela Gonzalez
    Messaoudi, Siwar
    Kalia, Yogeshvar N.
    PHARMACEUTICS, 2022, 14 (09)
  • [7] Non-invasive strategies for targeting the posterior segment of eye
    Madni, Asadullah
    Rahem, Muhammad Abdur
    Tahir, Nayab
    Sarfraz, Muhammad
    Jabar, Abdul
    Rehman, Mubashar
    Kashif, Prince Muhammad
    Badshah, Syed Faisal
    Khan, Kifayat Ullah
    Santos, Helder A.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2017, 530 (1-2) : 326 - 345
  • [8] Simultaneous amelioration of diabetic ocular complications in lens and retinal tissues using a non-invasive drug delivery system
    Srinivasarao, Dadi A.
    Reddy, S. Sreenivasa
    Reddy, G. Bhanuprakash
    Katti, Dhirendra S.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2021, 608
  • [9] To investigate fit-to-purpose nanocarrier for non-invasive drug delivery to posterior segment of eye
    Tambe, Vishakha
    Raval, Nidhi
    Gondaliya, Piyush
    Bhattacharya, Pallab
    Kalia, Kiran
    Tekade, Rakesh Kumar
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2021, 61
  • [10] Lipid Vesicles and Nanoparticles for Non-invasive Topical and Transdermal Drug Delivery
    Shabbir, Maryam
    Nagra, Uzair
    Zaman, Muhammad
    Mahmood, Asif
    Barkat, Kashif
    CURRENT PHARMACEUTICAL DESIGN, 2020, 26 (18) : 2149 - 2166